Haiping Song

Prof. Haiping Song


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
WSWeihong Sun
Weihong Sun
CJChangqing Jiang
Changqing Jiang
YJYing Ji
Ying Ji
CXChao Xiao
Chao Xiao
HSHaiping Song
Haiping Song
Gastric cancer (GC) is the second leading cause of cancer mortality and the fourth most commonly diagnosed malignant disease, with approximately 951,000 new cases diagnosed and approximately 723,000 cases of mortality each year. The highest mortality rate of GC is in East Asia, and the lowest is in North America. A large number of studies have demonstrated that GC patients are characterized by higher morbidity, metastasis rates, and mortality and lower early diagnosis rates, radical resection rates, and 5‐year survival rates. All cases of GC can be divided into two important stages, namely, early‐ and advanced‐stage GC, and the stage mainly determines the treatment strategy for and the therapeutic effect in GC patients. Patients with early‐stage GC undergo radical surgery followed by chemotherapy, and the 5‐year survival rate can be as high as 90%. However, patients with advanced‐stage GC cannot undergo radical surgery because they are at risk for metastasis; therefore, they can choose only radiotherapy or chemotherapy and have a poor prognosis. Based on the lack of specific clinical manifestations and detection methods, most GC patients (>70%) are diagnosed in the advanced stage; therefore, continued efforts toward developing treatments have been focused on advanced‐stage GC patients and include molecular targeted therapy, immunotherapy, and small molecular therapy. Nevertheless, in recent years, accumulating evidence has indicated that small molecules, especially long noncoding RNAs (lncRNAs), are involved in the occurrence, development, and progression of GC, and their abundantly dysregulated expression has been identified in GC tissues and cell lines. Therefore, lncRNAs are considered easily detectable molecules and ideal biomarkers or target‐specific agents for the future diagnosis or treatment of GC. In this review, we primarily discuss the status of GC, the role of lncRNAs in GC, and the emerging systemic treatments for GC.

1 January 2019
Verified
Journal Article
Closed access
WSWeihong Sun
Weihong Sun
SRShaoshao Ren
Shaoshao Ren
RLRan Li
Ran Li
QZQingshan Zhang
Qingshan Zhang
HSHaiping Song
Haiping Song

1 March 2020 in Panminerva Medica
Verified
Journal Article
Closed access
XWXin Wang
Xin Wang
HSHongquan Sun
Hongquan Sun
HSHaiping Song
Haiping Song
WSWeihong Sun
Weihong Sun
PZPeng Zhao
Peng Zhao
XMXuezhen Ma
Xuezhen Ma
Article: Clinical significance of PAX5 in lung adenocarcinoma and its role in cell proliferation and metastasis - Panminerva Medica 2020 Mar 30 - Minerva Medica - Journals